Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis

A Randomized, Open Label, Phase III Trial to Evaluate Radical Local Treatment versus Palliative Treatment for Breast Cancer Patients with Primary Ipsilateral Humerus or Sternum Oligometastasis

Trial Details

NCT ID
NCT04158843
Phase
NA
Sponsor
xuexin he
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Radical resection
  • Radical radiotherapy
  • Palliative treatment
Locations (sample)
  • Hangzhou, Zhejiang, China|30.29365,120.16142
  • Hangzhou, Zhejiang, China|30.29365,120.16142
  • Jiaxing, Zhejiang, China|30.7522,120.75
  • Lishui, Zhejiang, China|28.46042,119.91029

Key Eligibility Criteria

  • Patients provided written informed consent
  • Women aged 18-75 years old
  • Histologically confirmed breast cancer and after radical mastectomy
  • Patients of breast cancer with ipsilateral humerus or sternum oligometastasis, and there is no imaging evidence of other site metastases

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →